期刊文献+

心电学及生物标志物在急性肺栓塞诊疗中的价值探讨 被引量:6

Utility of dynamic ECG and biomarkers for diagnosis of acute pulmonary embolism
原文传递
导出
摘要 目的探讨心电学及生物标志物动态变化在急性肺栓塞诊疗和风险评估中的价值。方法回顾性分析近5年住院确诊的17例急性肺栓塞患者不同阶段的心电学特点及动态变化,结合D二聚体(D-D)、肌钙蛋白I(c Tn I)、B型脑利钠肽前体(Pre-BNP)、C反应蛋白(CRP)等生化指标进行分析比较。结果 1入院时心电图变化主要包括SⅠ>0.1 m V者9例,SⅠQⅢTⅢ者4例,a VR终末呈R波者10例,胸前导联T波倒置6例,窦性心动过速6例,完全/或不完全性右束支阻滞者2例。有效治疗后心率下降、心前区导联T波演变、TⅢ倒置变浅或转直立、QⅢ减小或消失,a VR终末R波振幅下降,QTcd降低。23例死亡病例SⅠ、QⅢTⅢ、avR终末R波以及广泛心前区导联T波倒置发生比率明显增高。死亡患者较存活病例QTcd明显增大[(80.2±34.5)ms/(74.8±33.7)ms]。3生物标志物DD(78.6%)、Pre-BNP(64.3%)、LDH(64.3%)、CK-MB(50.0%)升高最为常见。4死亡组DD、Pre-BNP和肌钙蛋白I/T的异常升高发生率均为100%,明显高于存活组。结论分析心电学及其动态变化,并结合血生物标志物,对急性肺栓塞的诊断、疗效评估、危险分层、预后判断具有十分重要的参考价值。 Objective To explore the clinic value of the dynamic changes of electrocardiology and biological markers in the diagnosis,treatment,and risk assessment of acute pulmonary thromboembolism. Methods Seventeen patients with acute pulmonary thromboembolism in recent 5 years were recruited in this study. The characteristics and dynamic change of electrocardiology as well as the biomarkers including D-D,c Tn I,Pre-BNP,and CRP were measured,analyzed and compared during different period in hospital. Results ① The electrocardiologic changes observed on the admission included as follows: 9 patients with SⅠ 0. 1 mv,4 patients with SⅠ,QⅢTⅢ,pattern,10 patients with terminal showing R wave in lead a VR,6 patients with T-wave inversion in precordial leads,6 patients with sinus tachycardia,and 2 patients with complete / incomplete right bundle branch block. After effective treatment,obvious ECG changes were observed in patients including the decrease in heart rate,the evolution of T wave in precordial leads( the transfer of T wave inversion to shallow and positive),reduction or disappear of QIII,decrease in the amplitude of terminal R wave in lead a VR,and decrease in the value of QTcd. ② The occurrence rate of SⅠ,QⅢTⅢ,terminal R wave in a VR,as well as extensive T-wave inversion in precordial leads was significantly elevated in 3 patients. The value of QTcd in died patients was significant higher than that in survived patient[( 80. 2 ± 34. 5) ms vs.( 74. 8 ± 33. 7) ms],P〈0. 05). ③ Blood biomarkers were elevated in patients as follows: DD( 78. 6%),Pre-BNP( 64. 3%),LDH( 64. 3%),and CK-MB( 50. 0%). ④ The blood DD,Pre-BNP,and I / T were all elevated in all died patients and was significantly higher than that in the survival group. Conclusion The dynamic monitoring of electrocardiology and blood biomarkers is valuable in the diagnosis,treatment,risk assessment,and prognosis judgment of patients with acute pulmonary thromboembolism.
出处 《中华全科医学》 2015年第5期716-718,851,共4页 Chinese Journal of General Practice
关键词 急性肺栓塞 心电学 生物标志物 Acute pulmonary embolism Electrophysiology Biomarkers
  • 相关文献

参考文献14

  • 1急性肺血栓栓塞症诊断治疗中国专家共识[J].中华内科杂志,2010,49(1):74-81. 被引量:398
  • 2Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep veinthrombosis[J]. Lancet,2012,379(9828) : 1835-1846.
  • 3Witting MD,Mattu A,Rogers R,et al. Simultaneous T-wave inversionsin anterior and inferior leads : an uncommon sign of pulmonary embol-ism[J]. J Emerg,2012,43(2) :228-235.
  • 4Zhong-Qun Z,Chong-Quan W,Nikus KC,et al. A new electrocardio-gram finding for massive pulmonary embolism : ST elevation in leadaVR with ST depression in leads I and V(4) to V(6) [ J]. Am JEmerg Med,2013 ,31 (2) :456. e5-8.
  • 5Ja.f MR,McMurtry MS,Archer SL,et al. Management of Massive andSub massive Pulmonary Embolism,Iliofemoral Deep Vein Thrombosis,and Chronic Thromboembolic Pulmonary Hypertension : A ScientificStatement From the American Heart Association [ J ]. Circulation,2011,123(16) :1788-1830.
  • 6Kostrubiec M,Hrynkiewicz A,Pedowska-Wloszek J,et al. It is possibleto use standard electrocardiography for risk assessment of patients withacute pulmonary embolismf J]. Kardiol Pol,2009 ,67(7) :744-750.
  • 7Vanni S, Polidofi G, Vergara R, et al. Prognostic value of ECG among patients with acute pulmonary embolism and normal blood pressure [J]. Am J Med,2009,122(3) :257-264.
  • 8Golpe R,Castro-AfS6n 0, P6rez-de-Llano LA,et al. Electrocardiogramscore predicts severity of pulmonary embolism in hemodynamically sta-ble patients[ J]. J Hosp Med,2011,6(5) :285-289.
  • 9Choi BY,Park DG. Normalization of negative T-wave on electrocardio-graphy and right ventricular dysfunction in patients with an acute pul-monary embolism[ J]. Korean J Intern Med,2012,27( 1) :53-59.
  • 10Kukla P, Dlugopolski R, Krupa E, et al. Electrocardiography andprognosis of patients with acute pulmonary embolism[ J]. Cardiol J,2011,18(6) :648-653.

二级参考文献57

  • 1荆志成,邓可武.急性肺动脉血栓栓塞症的溶栓治疗[J].中华医学杂志,2004,84(22):1932-1934. 被引量:20
  • 2邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 3Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatnlent of major pulmonary embolism. Ann Thorae Surg, 2004,77:819-823.
  • 4Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev, 2005, 19 : 179-202.
  • 5PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d' Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 2005,112:416-422.
  • 6Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients : an AAST multicenter study. J Trauma, 2007,62 : 17-24.
  • 7Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino) , 2008,49:35-49.
  • 8Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : a European nmlticenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239-245.
  • 9Dalla-Volta S, Palla A, Santolicandro A, et al. PALMS 2: aheplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 1992, 20:520-526.
  • 10Levine M, Hirsh J, Weitz J, et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest, 1990, 98: 1473-1479.

共引文献402

同被引文献46

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部